Medical cannabis pain relief clinic opens in Colombia

The Colomabian province of Barranquilla will be the first in the country to open a medical cannabis pain relief clinic, called “Integralgia”. The medical project is led by a team of anesthesiologists specializing in pain and trained in the formulation of medical cannabis, and it is expected that it will treat hundreds of patients with diseases like: Parkinson or alzheimer.

As Colombia advances in the emerging medical cannabis industry, reaching agreements with different international companies that will allow it to expand this sector considerably. Barranquilla, one of the main cities of the Latin American country, is a pioneer in the Caribbean Region with the opening of the first specialized cannabis clinic. 

This medical center will benefit patients with chronic diseases, who will be able to access specialized treatments applied by an interdisciplinary team, trained under the regulations established by the National Ministry of Health. 

It is expected that this cannabis clinic will help to combat the current stigmatization surrounding this plant and expand the knowledge about the many health benefits it has if used correctly.

If you want to know more about cannabis, how the Colombian province of Barranquilla will become a pioneer in the sector by opening the first specialized cannabis clinic, how the country is establishing alliances with many cannabis companies around the world, and to find out the latest hemp news, download the Hemp.im mobile application.

Medical cannabis could improve the quality of life of many patients

Gone is the myth that cannabis is only for recreational use. Its medicinal properties could improve the quality of life of patients with diseases such as epilepsy, Parkinson’s or Alzheimer’s and serve as a complementary treatment for those seeking to try other options. 

Patients with chronic pain may also benefit from this treatment, according to the medical indication. The Pain Clinic “Integralgia” leads this process in the city of Barranquilla with a team of anesthesiologists specializing in pain, neurologists, neurosurgeons, algesiologists and psychiatrists, who were formally trained in the formulation of medical cannabis in patients who require it.

Dr. Karina Perez, anesthesiologist specializing in pain management and palliative care, explains that the process begins with a case assessment to confirm whether the patient is a candidate for treatment and, once assessed, the doctor makes a formula prepared solely and exclusively for this patient.

“The initial assessment is made according to the type of symptom, condition or disease that is present. This could include patients with chronic pain, epilepsy that is difficult to control, cancer pain, lack of appetite, insomnia, among others”, explains the doctor.

Colombia’s cannabis industry has the potential to growth exponentially in the coming months 

In Colombia, since 2016, when law 1787 was passed, allowing the cultivation and manufacture of cannabis for medicinal purposes, free trade products have been distributed on the streets, some of them of dubious origin. Invima evaluations have found, in some of these products, contamination with sand and even organic materials such as feces. 

The opening of this medical center allows access to a safe product, which has all the legal permits, with the exact concentration of CBD and THC, and under the supervision of a specialized medical team.

Furthermore, during the past couple of months the colombian government has been establishing alliances and agreements with multinational cannabis corporations for the expansion of its cannabis business. This could generate millions in revenue to the country, and also combat the illegal cannabis market by offering quality products from all around the world at accessible prices.

__

(Featured image by Flavia Carpio via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in El Universal, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.